# C3.ai, Inc.: financial statements, quarterly

AI · NYSE · CIK 1577526 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/ai.md) · [Financials](/companies/ai/financials.md) · [Filings](/companies/ai/filings.md) · [Insiders](/companies/ai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ai/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [73.2](/filings/0001628280-24-050538.md) | [78.4](/filings/0001628280-25-011069.md) | [86.6 d](/filings/0001577526-26-000078.md) | [87.2](/filings/0001577526-25-000033.md) | [94.3](/filings/0001577526-25-000055.md) | [98.8](/filings/0001577526-26-000024.md) | [109 d](/filings/0001577526-26-000078.md) | [70.3](/filings/0001577526-26-000126.md) | [75.1](/filings/0001577526-25-000055.md) | [53.3](/filings/0001577526-26-000024.md) | [51.6 d](/filings/0001577526-26-000078.md) | [52.4](/filings/0001577526-26-000126.md) |
| Cost of revenue | $m | [32.1](/filings/0001628280-24-050538.md) | [33.1](/filings/0001628280-25-011069.md) | [35.0 d](/filings/0001577526-26-000078.md) | [35.0](/filings/0001577526-25-000033.md) | [36.5](/filings/0001577526-25-000055.md) | [40.4](/filings/0001577526-26-000024.md) | [41.2 d](/filings/0001577526-26-000078.md) | [43.8](/filings/0001577526-26-000126.md) | [44.8](/filings/0001577526-25-000055.md) | [44.0](/filings/0001577526-26-000024.md) | [40.3 d](/filings/0001577526-26-000078.md) | [35.7](/filings/0001577526-26-000126.md) |
| Gross profit | $m | [41.1](/filings/0001628280-24-050538.md) | [45.3](/filings/0001628280-25-011069.md) | [51.6 d](/filings/0001577526-26-000078.md) | [52.2](/filings/0001577526-25-000033.md) | [57.8](/filings/0001577526-25-000055.md) | [58.3](/filings/0001577526-26-000024.md) | [67.5 d](/filings/0001577526-26-000078.md) | [26.4](/filings/0001577526-26-000126.md) | [30.4](/filings/0001577526-25-000055.md) | [9.2](/filings/0001577526-26-000024.md) | [11.3 d](/filings/0001577526-26-000078.md) | [16.7](/filings/0001577526-26-000126.md) |
| Research and development | $m | [50.4](/filings/0001628280-24-050538.md) | [49.5](/filings/0001628280-25-011069.md) | [50.6 d](/filings/0001577526-26-000078.md) | [52.9](/filings/0001577526-25-000033.md) | [55.7](/filings/0001577526-25-000055.md) | [59.4](/filings/0001577526-26-000024.md) | [58.4 d](/filings/0001577526-26-000078.md) | [64.7](/filings/0001577526-26-000126.md) | [58.4](/filings/0001577526-25-000055.md) | [58.8](/filings/0001577526-26-000024.md) | [47.3 d](/filings/0001577526-26-000078.md) | [46.5](/filings/0001577526-26-000126.md) |
| Operating income | $m | [(79.4)](/filings/0001628280-24-050538.md) | [(82.5)](/filings/0001628280-25-011069.md) | [(82.3) d](/filings/0001577526-26-000078.md) | [(72.6)](/filings/0001577526-25-000033.md) | [(75.3)](/filings/0001577526-25-000055.md) | [(87.6)](/filings/0001577526-26-000024.md) | [(89.0) d](/filings/0001577526-26-000078.md) | [(125)](/filings/0001577526-26-000126.md) | [(112)](/filings/0001577526-25-000055.md) | [(140)](/filings/0001577526-26-000024.md) | [(121) d](/filings/0001577526-26-000078.md) | [(98.3)](/filings/0001577526-26-000126.md) |
| Income tax | $m | [0.2](/filings/0001628280-24-050538.md) | [0.5](/filings/0001628280-25-011069.md) | [(0.1) d](/filings/0001577526-26-000078.md) | [0.3](/filings/0001577526-25-000033.md) | [0.3](/filings/0001577526-25-000055.md) | [0.3](/filings/0001577526-26-000024.md) | [0.1 d](/filings/0001577526-26-000078.md) | [0.3](/filings/0001577526-26-000126.md) | [0.2](/filings/0001577526-25-000055.md) | [0.2](/filings/0001577526-26-000024.md) | [0.1 d](/filings/0001577526-26-000078.md) | [0.2](/filings/0001577526-26-000126.md) |
| Net income | $m | [(69.8)](/filings/0001628280-24-050538.md) | [(72.6)](/filings/0001628280-25-011069.md) | [(72.9) d](/filings/0001577526-26-000078.md) | [(62.8)](/filings/0001577526-25-000033.md) | [(66.0)](/filings/0001577526-25-000055.md) | [(80.2)](/filings/0001577526-26-000024.md) | [(79.7) d](/filings/0001577526-26-000078.md) | [(117)](/filings/0001577526-26-000126.md) | [(105)](/filings/0001577526-25-000055.md) | [(133)](/filings/0001577526-26-000024.md) | [(116) d](/filings/0001577526-26-000078.md) | [(92.8)](/filings/0001577526-26-000126.md) |
| Diluted EPS | $ per share | [(0.59)](/filings/0001628280-24-050538.md) | [(0.60)](/filings/0001628280-25-011069.md) | not reported | [(0.50)](/filings/0001577526-25-000033.md) | [(0.52)](/filings/0001577526-25-000055.md) | [(0.62)](/filings/0001577526-26-000024.md) | not reported | [(0.86)](/filings/0001577526-26-000126.md) | [(0.75)](/filings/0001577526-25-000055.md) | [(0.94)](/filings/0001577526-26-000024.md) | not reported | [(0.60)](/filings/0001577526-26-000126.md) |
| Basic EPS | $ per share | [(0.59)](/filings/0001628280-24-050538.md) | [(0.60)](/filings/0001628280-25-011069.md) | not reported | [(0.50)](/filings/0001577526-25-000033.md) | [(0.52)](/filings/0001577526-25-000055.md) | [(0.62)](/filings/0001577526-26-000024.md) | not reported | [(0.86)](/filings/0001577526-26-000126.md) | [(0.75)](/filings/0001577526-25-000055.md) | [(0.94)](/filings/0001577526-26-000024.md) | not reported | [(0.60)](/filings/0001577526-26-000126.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [149](/filings/0001628280-24-050538.md) | [115](/filings/0001628280-25-011069.md) | [167](/filings/0001577526-26-000078.md) | [134](/filings/0001577526-25-000033.md) | [121](/filings/0001577526-25-000055.md) | [125](/filings/0001577526-26-000024.md) | [164](/filings/0001577526-26-000078.md) | [80.9](/filings/0001577526-26-000126.md) | [103](/filings/0001577526-25-000055.md) | [88.8](/filings/0001577526-26-000024.md) | [66.2](/filings/0001577526-26-000126.md) | [136](/filings/0001577526-26-000126.md) |
| Current assets | $m | [931](/filings/0001628280-23-040969.md) | [926](/filings/0001628280-24-007744.md) | [904](/filings/0001628280-25-032604.md) | [926](/filings/0001628280-24-039467.md) | [918](/filings/0001628280-24-050538.md) | [931](/filings/0001628280-25-011069.md) | [904](/filings/0001577526-26-000078.md) | [851](/filings/0001577526-25-000033.md) | [846](/filings/0001577526-25-000055.md) | [783](/filings/0001577526-26-000024.md) | [708](/filings/0001577526-26-000126.md) | [770](/filings/0001577526-26-000126.md) |
| Total assets | $m | [1,071](/filings/0001628280-23-040969.md) | [1,064](/filings/0001628280-24-007744.md) | [1,038](/filings/0001628280-25-032604.md) | [1,058](/filings/0001628280-24-039467.md) | [1,046](/filings/0001628280-24-050538.md) | [1,055](/filings/0001628280-25-011069.md) | [1,026](/filings/0001577526-26-000078.md) | [969](/filings/0001577526-25-000033.md) | [961](/filings/0001577526-25-000055.md) | [896](/filings/0001577526-26-000024.md) | [816](/filings/0001577526-26-000126.md) | [875](/filings/0001577526-26-000126.md) |
| Current liabilities | $m | [114](/filings/0001628280-23-040969.md) | [109](/filings/0001628280-24-007744.md) | [102](/filings/0001628280-25-032604.md) | [118](/filings/0001628280-24-039467.md) | [122](/filings/0001628280-24-050538.md) | [138](/filings/0001628280-25-011069.md) | [132](/filings/0001577526-26-000078.md) | [111](/filings/0001577526-25-000033.md) | [131](/filings/0001577526-25-000055.md) | [119](/filings/0001577526-26-000024.md) | [107](/filings/0001577526-26-000126.md) | [125](/filings/0001577526-26-000126.md) |
| Total liabilities | $m | [160](/filings/0001628280-23-040969.md) | [166](/filings/0001628280-24-007744.md) | [165](/filings/0001628280-25-032604.md) | [183](/filings/0001628280-24-039467.md) | [187](/filings/0001628280-24-050538.md) | [195](/filings/0001628280-25-011069.md) | [188](/filings/0001577526-26-000078.md) | [170](/filings/0001577526-25-000033.md) | [189](/filings/0001577526-25-000055.md) | [176](/filings/0001577526-26-000024.md) | [163](/filings/0001577526-26-000126.md) | [180](/filings/0001577526-26-000126.md) |
| Shareholders' equity | $m | [911](/filings/0001628280-25-011069.md) | [898](/filings/0001628280-25-011069.md) | [873](/filings/0001577526-26-000078.md) | [875](/filings/0001577526-25-000055.md) | [859](/filings/0001577526-26-000024.md) | [860](/filings/0001577526-26-000024.md) | [838](/filings/0001577526-26-000126.md) | [799](/filings/0001577526-26-000126.md) | [772](/filings/0001577526-26-000024.md) | [719](/filings/0001577526-26-000024.md) | [654](/filings/0001577526-26-000126.md) | [695](/filings/0001577526-26-000126.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(48.6) d](/filings/0001628280-24-050538.md) | [(39.1) d](/filings/0001628280-25-011069.md) | [21.3 d](/filings/0001577526-26-000078.md) | [8.0](/filings/0001577526-25-000033.md) | [(38.7) d](/filings/0001577526-25-000055.md) | [(22.0) d](/filings/0001577526-26-000024.md) | [11.3 d](/filings/0001577526-26-000078.md) | [(33.5)](/filings/0001577526-26-000126.md) | [(46.5) d](/filings/0001577526-25-000055.md) | [(55.8) d](/filings/0001577526-26-000024.md) | [(54.4) d](/filings/0001577526-26-000078.md) | [2.1](/filings/0001577526-26-000126.md) |
| Capital expenditure | $m | [5.3 d](/filings/0001628280-24-050538.md) | [6.1 d](/filings/0001628280-25-011069.md) | [2.5 d](/filings/0001577526-26-000078.md) | [0.9](/filings/0001577526-25-000033.md) | [0.8 d](/filings/0001577526-25-000055.md) | [0.4 d](/filings/0001577526-26-000024.md) | [0.9 d](/filings/0001577526-26-000078.md) | [0.8](/filings/0001577526-26-000126.md) | [0.4 d](/filings/0001577526-25-000055.md) | [0.4 d](/filings/0001577526-26-000024.md) | [0.3 d](/filings/0001577526-26-000078.md) | [0.0](/filings/0001577526-26-000126.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0001628280-23-040969.md) | [111](/filings/0001628280-24-007744.md) | [116](/filings/0001628280-24-039467.md) | [119](/filings/0001628280-24-050538.md) | [120](/filings/0001628280-25-011069.md) | [125](/filings/0001577526-25-000033.md) | [128](/filings/0001577526-25-000055.md) | [130](/filings/0001577526-26-000024.md) | [135](/filings/0001577526-26-000126.md) | [139](/filings/0001577526-25-000055.md) | [142](/filings/0001577526-26-000024.md) | [155](/filings/0001577526-26-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.